Aneuploidy is defined as an alteration in chromosome number that is not a multiple of the haploid complement. Such karyotypic changes are associated with human disease. Aneuploidy is the leading cause of miscarriages and mental retardation in humans. It is also a hallmark of cancer: more than 90% of all solid human tumors are aneuploid. In order to shed light on the relationship between aneuploidy and cancer we must understand how aneuploidy affects the physiology of normal cells. We have developed several cell models of aneuploidy in yeast and mouse to address this question. Our studies in yeast revealed a set of phenotypes shared among many different aneuploidies, which we call the aneuploidy-associated stresses. They include a transcriptional stress response, a cell proliferation defect, increased need for energy, genome instability and proteotoxic stress. Importantly, our studies in mammalian cells revealed that these aneuploidy-associated stresses are conserved across eukaryotes. This discovery indicates that our studies in yeast will provide critical insights into how the aneuploid condition affects mammalian cell physiology and tumorigenesis. Here we propose to study two aneuploidy-associated phenotypes and to investigate how they are connected. We will determine the molecular basis for aneuploidy-induced proteotoxicity and how it contributes to the proliferation defects of aneuploid cells. In addition, we will explore the exciting possibility of a link between aneuploidy and aging.
In Specific Aim 1 we will determine how proteomic imbalances caused by aneuploidy lead to proteotoxic stress. Specifically, we will distinguish between the possibilities that protein qualit control pathways are defective or overwhelmed in aneuploid cells.
In Specific Aim 2 we will determine how proteotoxic stress impacts cell proliferation, especially the G1 - S phase transition that is found to be impaired in many different aneuploid yeast strains. Finally, in Specific Aim 3 we will investigate whether aneuploidy is a cause of aging. Our preliminary data raise this exciting possibility. We will now determine whether aneuploidy increases with replicative age and whether specific aneuploidies cause the phenotypes that are so characteristic of aging. Cancers are highly aneuploid and under profound proteotoxic stress. Determining which protein quality control pathways are vulnerable in cells with an altered karyotype is thus highly relevant to understanding the physiological state of cancer cells. Given that the cellular phenotypes of aging are conserved across eukaryotes our investigation of the relationship between aneuploidy and aging is likely to also have important implications for cellular aging in humans.

Public Health Relevance

Aneuploidy is the leading cause of miscarriages and mental retardation in humans. It is also a hallmark of cancer. More than 90% of all solid human tumors are aneuploid. Understanding the impact of aneuploidy on cellular physiology is thus vital if we want to make progress towards understanding this disease. The long-term goal of our studies is to define this impact. Specifically, we will focus on determining how proteomic alterations caused by aneuploidy lead to proteotoxic stress and proliferation defects in aneuploid cells. We use the budding yeast S. cerevisiae as a model system to address this question. Given that the processes governing cellular protein homeostasis and cell division are highly conserved from yeast to man, it is likely that our studies in yeast will provide the foundation for determining th effects of aneuploidy on normal human cells and cancer cells.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA206157-22
Application #
9222726
Study Section
Cellular Signaling and Regulatory Systems Study Section (CSRS)
Program Officer
Witkin, Keren L
Project Start
1997-09-30
Project End
2021-01-31
Budget Start
2017-02-01
Budget End
2018-01-31
Support Year
22
Fiscal Year
2017
Total Cost
$260,257
Indirect Cost
$89,257
Name
Massachusetts Institute of Technology
Department
Internal Medicine/Medicine
Type
Schools of Arts and Sciences
DUNS #
001425594
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Knouse, Kristin A; Lopez, Kristina E; Bachofner, Marc et al. (2018) Chromosome Segregation Fidelity in Epithelia Requires Tissue Architecture. Cell 175:200-211.e13
Santaguida, Stefano; Richardson, Amelia; Iyer, Divya Ramalingam et al. (2017) Chromosome Mis-segregation Generates Cell-Cycle-Arrested Cells with Complex Karyotypes that Are Eliminated by the Immune System. Dev Cell 41:638-651.e5
Beach, Rebecca R; Ricci-Tam, Chiara; Brennan, Christopher M et al. (2017) Aneuploidy Causes Non-genetic Individuality. Cell 169:229-242.e21
Sheltzer, Jason M; Ko, Julie H; Replogle, John M et al. (2017) Single-chromosome Gains Commonly Function as Tumor Suppressors. Cancer Cell 31:240-255
Dodgson, Stacie E; Santaguida, Stefano; Kim, Sharon et al. (2016) The pleiotropic deubiquitinase Ubp3 confers aneuploidy tolerance. Genes Dev 30:2259-2271
Torres, Eduardo M; Springer, Michael; Amon, Angelika (2016) No current evidence for widespread dosage compensation in S. cerevisiae. Elife 5:e10996
Dodgson, Stacie E; Kim, Sharon; Costanzo, Michael et al. (2016) Chromosome-Specific and Global Effects of Aneuploidy in Saccharomyces cerevisiae. Genetics 202:1395-409
Knouse, Kristin A; Wu, Jie; Amon, Angelika (2016) Assessment of megabase-scale somatic copy number variation using single-cell sequencing. Genome Res 26:376-84
Pfau, Sarah J; Silberman, Rebecca E; Knouse, Kristin A et al. (2016) Aneuploidy impairs hematopoietic stem cell fitness and is selected against in regenerating tissues in vivo. Genes Dev 30:1395-408
Bonney, Megan E; Moriya, Hisao; Amon, Angelika (2015) Aneuploid proliferation defects in yeast are not driven by copy number changes of a few dosage-sensitive genes. Genes Dev 29:898-903

Showing the most recent 10 out of 11 publications